<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20161127031131N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-10</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Guided radial artery cannulation in patient undergoing cardiac</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of ultrasound-guided radial artery cannulation with Doppler guidance technique and palpation technique in patient undergoing cardiac surgery referred to Shahid Rajaei Heart Center in Tehran: A clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>300</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63132</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, patients are randomly assigned to three equal groups and for random allocation, permuted block randomization with hexagonal blocks is used, Blinding description: In this study, the patient is unaware of which group he is in, but the patient's caregivers (physician and nurse) and statistical analyst are aware.
In this study, after obtaining the patient's consent, it is explained that he is in one of the three groups of touch, Doppler or ultrasound.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Radial artery cannulation.</hc_freetext>
      <i_freetext>Intervention 1: Control group: For cannulation with palpation technique , the anesthesiologist touches the pulse of the radial artery with a non-dominant hand. The catheter will be advanced towards the radial artery, at 15–30 degrees to the skin, until blood observes in the catheter hub, Guidewire is then inserted through the needle. The leader catheter is then connected to the transducer so that arterial waves appear on the monitoring screen. Intervention 2: Intervention group: Doppler group: In the Doppler-guided radial artery cannulation method, the Doppler probe is placed in the non-dominant hand of the anesthesiologist to determine the location of the highest pulsating signal. The needle is inserted through the anesthetized skin. An increase or decrease in Doppler tone is a sign that the needle is being pressed against the artery. The needle is then pushed forward until the Doppler tone returns to baseline (indicating reopening of the artery) or pulsating blood appears at the end of the needle. Guidewire is then inserted through the needle and after removing the needle, the leader catheter is placed in place. The leader catheter is then connected to the transducer so that arterial waves appear on the monitoring screen. Intervention 3: Intervention group: Ultrasound group: For ultrasound-guided arterial cannulation, the ultrasound probe detects the radial artery perpendicular to its longitudinal axis approximately 5 mm proximal to the skin puncture site. The needle is pushed at an angle of 15-30 degrees to the skin until the catheter tip is visible on the screen. The position of the catheter is adjusted until the tip of the catheter comes in contact with the artery. Guidewire is then inserted through the needle and after removing the needle, the leader catheter is placed in place. The leader catheter is then connected to the transducer so that arterial waves appear on the monitoring screen.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentified individuals

When:
Data will be available after the article is published

To whom:
Information will be available to academic researchers

Conditions:
Use of information is permitted provided the source is acknowledge

Where to obtain:
Applicants can request the required information by sending an email to yasmin.chaibakhsh@gmail.com

How to obtain:
Information will be sent to them within one week of sending the email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Yasmin Chaibakhsh Langroudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shaheed Rajaie Cardiovascular, Medical &amp; Research Center</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1995614331</zip>
        <telephone>+98 21 23921</telephone>
        <email>yasmin.chaibakhsh@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rasoul Azarfarin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shaheed Rajaie Cardiovascular, Medical &amp; Research Center</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1995614331</zip>
        <telephone>+98 21 23921</telephone>
        <email>azarfarinr@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over 18 years of age undergoing cardiac surgery</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients under 18 years
Patients with peripheral vascular disease
Patients with vascular collagen diseases
Patients with inflamed skin near the puncture site
Patients with cold and mottled skin and weak capillary refill
Patients who have undergone radial artery cannulation for the past 30 days</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: For cannulation with palpation technique , the anesthesiologist touches the pulse of the radial artery with a non-dominant hand. The catheter will be advanced towards the radial artery, at 15–30 degrees to the skin, until blood observes in the catheter hub, Guidewire is then inserted through the needle. The leader catheter is then connected to the transducer so that arterial waves appear on the monitoring screen.</i_keyword>
      <i_keyword>Intervention group: Doppler group: In the Doppler-guided radial artery cannulation method, the Doppler probe is placed in the non-dominant hand of the anesthesiologist to determine the location of the highest pulsating signal. The needle is inserted through the anesthetized skin. An increase or decrease in Doppler tone is a sign that the needle is being pressed against the artery. The needle is then pushed forward until the Doppler tone returns to baseline (indicating reopening of the artery) or pulsating blood appears at the end of the needle. Guidewire is then inserted through the needle and after removing the needle, the leader catheter is placed in place. The leader catheter is then connected to the transducer so that arterial waves appear on the monitoring screen.</i_keyword>
      <i_keyword>Intervention group: Ultrasound group: For ultrasound-guided arterial cannulation, the ultrasound probe detects the radial artery perpendicular to its longitudinal axis approximately 5 mm proximal to the skin puncture site. The needle is pushed at an angle of 15-30 degrees to the skin until the catheter tip is visible on the screen. The position of the catheter is adjusted until the tip of the catheter comes in contact with the artery. Guidewire is then inserted through the needle and after removing the needle, the leader catheter is placed in place. The leader catheter is then connected to the transducer so that arterial waves appear on the monitoring screen.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Success in the first attempt at cannulation. Timepoint: The time of the first puncture. Method of measurement: See blood at the end of the leader cath And measure its time.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Cannulation time: It is a measured time from skin puncture to successful cannulation, which is described as the observation of blood at the end of the lead. Timepoint: From skin puncture to successful cannulation, which takes less than 5 minutes, is considered a successful procedure. Method of measurement: Successful cannulation in 5 minutes using a stopwatch.</sec_outcome>
      <sec_outcome>Examination of complications such as arterial spasm, hematoma, infection, thrombosis, ischemia, complex pain syndrome, which will be followed up in the intensive care unit up to 72 hours later. Timepoint: The patient's hand in which the radial artery cannulation has been performed will undergo a clinical examination for complications immediately after the procedure (0), 24, 48 and 72 hours after the procedure. Method of measurement: Physical examination.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-25</approval_date>
        <contact_name>کمیته اخلاق دانشگاه علوم پزشکی ایران</contact_name>
        <contact_address>Shaheed Rajaie Cardiovascular, Medical &amp; Research Center Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
